251 related articles for article (PubMed ID: 19723045)
1. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
2. Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients.
Sulkowska M; Wincewicz A; Sulkowski S; Koda M; Kanczuga-Koda L
Pathology; 2009; 41(3):254-60. PubMed ID: 19142800
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction.
Yamamoto M; Fukuda K; Miura N; Suzuki R; Kido T; Komatsu Y
Hepatology; 1998 Apr; 27(4):959-66. PubMed ID: 9537434
[TBL] [Abstract][Full Text] [Related]
4. Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Sulkowski S
Pathology; 2007 Jun; 39(3):334-8. PubMed ID: 17558861
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
6. Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells.
Teramoto T; Kiss A; Thorgeirsson SS
Biochem Biophys Res Commun; 1998 Oct; 251(1):56-60. PubMed ID: 9790906
[TBL] [Abstract][Full Text] [Related]
7. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
8. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
Han HS; Park YM; Hwang TS
J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
[TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
11. Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer.
Koda M; Reszec J; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Ann N Y Acad Sci; 2004 Dec; 1030():377-83. PubMed ID: 15659820
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta superfamily members, ActivinA and TGF-beta1, induce apoptosis in oligodendrocytes by different pathways.
Schulz R; Vogel T; Dressel R; Krieglstein K
Cell Tissue Res; 2008 Dec; 334(3):327-38. PubMed ID: 19002501
[TBL] [Abstract][Full Text] [Related]
13. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Kanczuga-Koda L; Witkowska E; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():53-61. PubMed ID: 17404017
[TBL] [Abstract][Full Text] [Related]
14. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability.
Miquel C; Borrini F; Grandjouan S; Aupérin A; Viguier J; Velasco V; Duvillard P; Praz F; Sabourin JC
Am J Clin Pathol; 2005 Apr; 123(4):562-70. PubMed ID: 15743744
[TBL] [Abstract][Full Text] [Related]
15. [Significance of cancer cell growth and apoptosis in morphogenesis of colorectal cancer].
Seki H
Hokkaido Igaku Zasshi; 2000 Sep; 75(5):325-34. PubMed ID: 11070793
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
17. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer.
Guzińska-Ustymowicz K; Sulkowska M; Famulski W; Sulkowski S
Anticancer Res; 2003; 23(1B):649-53. PubMed ID: 12680162
[TBL] [Abstract][Full Text] [Related]
18. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
[TBL] [Abstract][Full Text] [Related]
20. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
